Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.06 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.21 | 0.08 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-05 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.08 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0005 |